Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when Verano Holdings Corp. publishes a filing, an earnings call transcript or a press release.
Get VRNO alertsGeorge Arcos is recorded as CEO at Verano Holdings Corp. (VRNO). George Arcos has spoken on 3 earnings calls across 1 company, most recently for Verano Holdings Corp. on October 29, 2026. Verano Holdings Corp. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Verano Holdings Corp. includes George Archos (CEO and Board Member), Richard Tarapchak (CFO), Trip McDermott (COO) and 7 others.
“On an annual basis, our third quarter and year-to-date results reflect strong organic growth and a significant increase in cash flow from operations. And I am proud of our teams for driving continued momentum throughout the year.”
“I'm thrilled to outline our strong second quarter results, highlighted by organic growth and the third consecutive quarter of revenue gains that also outperformed the prior year period.”
“Before outlining our first quarter results, I would like to acknowledge last week's transformative announcement that state-licensed medical cannabis has been rescheduled to Schedule 3 with immediate effect.”
Drug Manufacturers - Specialty & Generic · Healthcare
CEO